Testicular cancer - An update;Hodentumoren - Eine aktuelle übersicht

Praxis

Volumn 92, Issue 47, 2003, Pages 1989-1997

  Buse, St ^a   Lurati, G ^a   Schmid, H P ^a  

^a Kantonsspital St Gallen Klinik fur Urologie   (Switzerland)

Author keywords

Review article; Testicular cancer; Urologic neoplasms

Indexed keywords

TUMOR MARKER;

ADULT; BIOPSY; CANCER STAGING; ECHOGRAPHY; HUMAN; LEYDIG CELL TUMOR; LYMPHOMA; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; PROGNOSIS; REVIEW; SEMINOMA; TESTIS; TESTIS TUMOR;

ADULT; BIOPSY; COMBINED MODALITY THERAPY; HUMANS; LEYDIG CELL TUMOR; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; SEMINOMA; TESTICULAR NEOPLASMS; TESTIS; TUMOR MARKERS, BIOLOGICAL; ULTRASONOGRAPHY;

EID: 2142798033     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024//0369-8394.92.47.1989     Document Type: Review

References (65)

1. Hartmann JT., Kuczyk M., Bokemeyer C.: Hodentumoren. Aus Onkologie heute-Urogenitale Carcinome. Springer Verlag, Wien, 15-56, 2001.
2. Oliver RTD.: Testicular cancer. Current Opinion in Oncology, 13, 191-198, 2001.
3. Buetow SA.: Epidemiology of testicular cancer. Epidemiol Rev, 17, 433-448, 1995.
4. Albers P.: Diagnostik und Therapie von Hodentumoren. Urologe A 41, 374-387, 2002.
5. WHO Daten, www. globocan, 2001, www. iarc, 2001.
6. Bosl GJ., Bajorin D., Sheinfeld J., Motzer R.: Cancer of the testis. Aus: De Vita, V.T., Hellman, S., Rosenberg, S., eds. Cancer: Principles and Practice of Oncology 5th edition, Philadelphia, J.B. Lippincott, 1397-1425, 1997.
7. Bosl GJ., Motzer RJ.: Testicular Germ-Cell Cancer. N Engl J Med, 337, 242-253, 1997.
8. Daniels JL., Stutzman RE., Mc Leod DG.: A comparison of testicular tumors in black and white patients. J Urol, 125, 341-342, 1981. (Pubitemid 11143534)
9. Senturia JD.: The epidemiology of testicular cancer. Br J Urol, 60, 285-291, 1987.
10. Nichols CR.: Testicular cancer. Curr Probl Cancer, 22, 187-274, 1998.
11. Stone JM., Cruickshank DG., Sandeman TF., et al. Laterality, maldescent, trauma and other clinical factors in the epidemiology of testis cancer in Victoria, Australia. Br J Cancer, 64, 132-138, 1991.
12. Osterlind A., Berthelsen JG., Abildgaard N., et al.: Risk of bilateral testicular germ cell cancer in denmark: 1960-1984. J Natl Cancer Inst, 83, 1391-1395, 1991.
13. Dieckmann KP., Boeckmann W., Brosig W., et al.: Bilateral testicular germ cell tumors: Report of nine cases and review of the literature. Cancer, 57, 1254-1258, 1986. (Pubitemid 16166242)
14. Rapley E., Crockford G., Teare D., et al.: Localisation to Xq 27 of a susceptibility gene for testicular germ cell tumors. Nat Genet, 24, 197-200, 2000. (Pubitemid 30094725)
15. Forman D., Oliver RTD., Brett AR., et al.: Familiar testicular cancer: A report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer, 65, 255-262, 1992.
16. Dearnaley DP., Huddart RA., Horwich A.: Managing testicular cancer. BMJ, 322, 1583-1588, 2001.
17. Dieckmann KP., Becker T., Jonas D., et al.: Inheritance and testicular cancer: Arguments based on a report of 3 cases and a review of the literature. Oncology, 44, 367-377, 1987. (Pubitemid 17160607)
18. Coldman AJ., Elwood JM., Gallagher RP.: Sports activities and risk of testicular cancer. Br J Cancer, 46, 749-756, 1982. (Pubitemid 13204416)
19. Batata MA., Chu FCH., Hilaris BS., et al.: Testicular cancer in cryptorchids. Cancer, 49, 1023, 1982.
20. Davies JM.: Testicular cancer in England and Wales: some epidemiological aspects. Lancet, 1, 928-932, 1981.
21. Depue RH., Pike MC., Henderson BE.: Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst, 71, 1151-1155, 1983. (Pubitemid 14182045)
22. Coleman MP., Estève J., Damiecki P., et al. : Testis. In : Trends in cancer incidence and mortality. Lyon, France:International agency for research on cancer, 121,529-542, 1993.
23. Dieckmann KP.: Die kontralaterale Biopsie beim Hodentumor. Ein Plädoyer dafür. Urologe A, 39, 260-266, 2000.
24. Vos A., Oosterhuis W., De Jong B., et al. : Cytogenetics of carcinoma in situ of the testis. Cancer Genet Cytogenet, 46, 75-81, 1990. (Pubitemid 20164932)
25. Rodriguez E., Matthews S., Reuter V., et al.: Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res, 52, 2285-2291, 1992.
26. Bosl GJ., Ilson DH., Rodriguez E., et al.: Clinical Relevance of the i(12p) Marker Chromosom in germ cell tumors. J Natl Cancer Inst, 86, 349-355, 1994. (Pubitemid 24076874)
27. Mostert MMC., van de Pol M., Olde-Weghuis D., et al. : Comparitive genomic hybridisation of germ cell tumors of the adult testis : Confirmation of Karyotypic findings and identification of a 12p amplicon. Cancer Genet Cytogenet, 89, 146-152, 1996. (Pubitemid 26286753)
28. Krege S., Souchon R., Schmoll HJ.: Interdisciplinary consensus on Diagnosis and Treatment of testicular germ cell tumors: Result of an update conference of Evidencend Based Medicine. Eur Urol, 40, 372-391, 2001. (Pubitemid 34036524)
29. Melchior D., Müller SC.: Das akute Skrotum. Urologe A, 39, 274-284, 2000. (Pubitemid 30365359)
30. Lamerz R., Albrecht W., Bialk, P., et al: Tumour Markers in Germ Cell Cancer: EGTM Recommendations. Anticancer Res, 19, 2795- 2798, 1999.
31. Dueland S., Stenwig AE., Heilo A., et al.: Treatment and outcome of patients with extragonadal germ cell tumours- The Norwegian Radium Hospitals Experience 1979-1994. Br J Cancer, 77, 329-335, 1998. (Pubitemid 28029552)
32. Hartman M., Pottek T., Bussar-Maatz R., et al.: Elevated human chorionic gonadotropin concentrations in the testicular vein and peripheral venous blood in seminoma patients. An analysis various parameters. Eur Urol, 31, 408-413, 1997. (Pubitemid 27234628)
33. Mencel PJ., Motzer RJ., Mazumdar M., et al.: Advanced Seminoma : Treatment results survival and prognostic factors in 142 patients. J Clin Oncol, 12, 120-126, 1994.
34. Toner GC., Geller NL., Tan C., Nisselbaum J., Bosl GJ.: Serum tumormarker halflife during chemotherapie allows early prediction of complete response and survival in non seminomatous germ cell tumours. Cancer Res, 50, 5904-5910, 1990. (Pubitemid 20331398)
35. Lashley D., Lowe B.: A rational approach to managing stage I non seminomatous germ cell cancer. Urol Clin North Am, 25, 405-423, 1998. (Pubitemid 28384606)
36. Leibovitch I., Foster RS., Kopecky KK., et al.: Identification of clinical stage A none seminomatous testis cancer patients at extremely low risk for metastatic desease: A combined approach using quantitative immunohistochemical, histopathologic and radiologic assessment. J Clin Oncol, 16, 261-286, 1998.
37. White PM., Adamson DJA., Howard GCW., et al.: Imaging of the thorax in the management of germ cell testicular tumors. Clin Radiol, 54, 207-211, 1999. (Pubitemid 29178859)
38. Bellin M., Roy C., Kinkel K., et al.: Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles- Initial clinical experience. Radiology, 207, 799-808, 1998. (Pubitemid 28279916)
39. Cremerius U., Wildberger JE., Borchers H., et al.: Does positon emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer? Results of a study of 50 patients. Urology, 54, 900-904, 1999. (Pubitemid 29505594)
40. Weber WA., Avril N., Schwaiger M.: Relevance of positron emission tomography in oncology. Strahlenther Onkol, 175, 356-376, 1999.
41. Capelouto CC., Clark PE., Ransil BJ., et al.: A review of scrotal violation in testicular cancer : Is adjuvant local therapy necessary? J Urol, 153, 981-985, 1995.
42. Heidenreich A., Höltl W., Albrecht W., et al: Testis-preserving surgery in bilateral testicular germ cell tumors. Br J Urol, 79, 253-257, 1997.
43. Dieckmann KP., Loy V.: Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol, 14, 3126-3132, 1996.
44. Weissbach L., Bamberg M., Schmoll HJ.: Interdisziplinäre Konsensuskonferenz zur "Diagnostik und Therapie von Hodentumoren". Urologe A, 36, 362-368, 1997. (Pubitemid 27317230)
45. Classen J., Dieckmann KP., Loy V., Bamberg M.: Die testikuläre intraepitheliale Neoplasie (TIN). Indikation zur Strahlentherapie? Strahlenther Onkol, 174, 173-177, 1998. (Pubitemid 28173447)
46. Kliesch S., Behre HM., Jürgens H., et al.: Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol, 26, 20-27, 1996. (Pubitemid 126507798)
47. Kliesch S., Kamischke A., Nieschlag E. Cryopreservation of sperm; in Nieschlag E., Behre HM.(eds.: Andrology- Male Reproductive Health and Dysfunction. Springer, Berlin, 349-358, 1997.
48. Dodds L., Marrett LD., Tomkins DJ., et al.: Case-control study of congenital anomalies in children of cancer patients. Br Med J,307, 164-168, 1993. (Pubitemid 23199979)
49. Bamberg M., Schmidberger H., Meisner C., et al.: Radiotherapy for stage I, IIA/B testicular seminoma. Int J Cancer, 83, 823-827, 1999.
50. Warde P., Gospodarowicz MK., Banerjee D., et al. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol 157, 1705-1710, 1997. (Pubitemid 27171758)
51. Von der Maase H.: Prognostic factors for stage I seminoma. UICC- symposium on Testicular Cancer, Tübingen, Abstractband, 21-22, 1999.
52. Mead GM., Stenning SP., Cook P.,et al.: International germ cell consenus classification: a prognostic Factor- erased staging system for metastatic germ cell cancers. J Clin Oncol, 15, 594-603, 1997. (Pubitemid 27074227)
53. Zon RT., Nichols C., Einhorn LH.: Management strategies and outcomes of germ cell tumor patients with very high human chorionic gonadotropin levels. J Clin Oncol, 16, 1294-1297, 1998. (Pubitemid 28175742)
54. Miller KD., Lohrer PJ., Gonin R., et al.: Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma. J Clin Oncol, 15, 1427-1431, 1997. (Pubitemid 27167375)
55. Böhlen D., Borner M., Sonntag RW., Fey MF., Studer UE.: Long term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol, 161, 1148-1152, 1999. (Pubitemid 29426106)
56. Donohue JP., Thornhill JA., Foster RS., et al.: Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965-1989): Modifications of technique and impact on ejaculation. J Urol, 149, 237-243, 1993. (Pubitemid 23097564)
57. Travis L., Andersson M., Holowarty E., et al.: Risk of leukaemia following radiotherapy and chemotherapy for testicular cancer. Proc Am Soc clin Oncol, 18:308a(abstract 1185), 1999.
58. Weissbach L., Bussar-Maatz R., Flechtner H., et al.: RPLND or primary chemotherapy in clinical stage II A/B non-seminomatous germ cell tumors? - Results of a prospective multicentre trial including quality of life assesement. Eur Urol, 37, 582-594, 2000. (Pubitemid 30189828)
59. Donohue JP., Thornhill JA., Foster RS., et al.:The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: The Indiana University experience (1965-1989). J Urol, 153, 85-89, 1995. (Pubitemid 24379804)
60. De Wit R, Stoter G., Sleijfer DT., et al.: Four cycles of BEP vs. four cycles VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization of Research and Treatment of Cancer. Br J Cancer, 78, 828-832, 1998.
61. Hartmann JT., Schmoll HJ., Kuczyk MA., et al.: Post-chemotherapy resections of residual masses from metastatic non seminomatous germ cell tumors. Ann Oncol, 8, 531-538, 1997.
62. Fossa SD., Stenning SP., Gerl A., et al.: Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours. Br J Cancer, 80, 1392-1399, 1999. (Pubitemid 29308608)
63. Weissbach L.: Guidelines for the diagnosis and therapy of testicular cancer and new developments. Urol Int, 63, 46-56, 1999.
64. Laguna MP., Pizzocaro G., Kleep O., et al.: EAU guidelines on testicular cancer. Eur Urol, 40, 102-110, 2001. (Pubitemid 32786094)
65. Cochlin D., Dubbins, PA., Goldberg BB., Urogenital Ultasound, A Text Atlas, Chapman and Hall, London, Glasgow, Weinheim, New York, Tokyo, Melbourne, Madras,1994.